Cinqair (reslizumab) has been approved by the U.S.Food and Drug Administration to treat serious asthma among adults 18 and older.
12 Aug '24 10:39AM
09 Aug '24 16:35PM
09 Aug '24 16:25PM
09 Aug '24 15:37PM